Additional file 5: of Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity
Tomoko Ikeda(Tohoku University), Hideo Harigae(Tohoku University Hospital), Tsuyoshi Shirai(Tohoku University), Yuko Shirota(Tohoku University), Hiroshi Fujii(Tohoku University), Masato Nose(Meiji University), Yukiko Kamogawa(Tohoku University), Tomonori Ishii(Tohoku University)
Cited by 0
Related Papers
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
|Immunity|1999|2.7k
The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease
|The Journal of Experimental Medicine|2016|534
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523
Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion
|Proceedings of the National Academy of Sciences|2002|398